Status:
RECRUITING
Decision Support Training for Advanced Cancer Family Caregivers: The CASCADE Factorial Trial
Lead Sponsor:
University of Alabama at Birmingham
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Family Members
Cancer
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
Using a highly innovative methodology, the Multiphase Optimization Strategy (MOST), the purpose of this randomized factorial trial is to identify components of a intervention (CASCADE) to enhance the ...
Detailed Description
A priority focus in oncology and palliative care is preparing the 3.2 million U.S. family caregivers of persons with cancer to effectively partner with patients in health-related decision-making from ...
Eligibility Criteria
Inclusion
- FAMILY CAREGIVERS
- ≥21 years of age;
- self-endorsing or identified by the patient as "a relative, friend, or partner that has a close relationship with you and who assists you with your medical decisions and who may or may not live in the same residence as you and who is not paid for their help";
- caring for a patient with advanced-stage cancer (see definition under Patient Inclusion criteria below);
- caregivers will need to have an agreeable patient willing to participate in the study for data collection; and
- English-speaking and able to complete baseline measures.
Exclusion
- 1\) Self-reported mental illness (i.e., schizophrenia, bipolar disorder, or major depressive disorder), dementia, active suicidal ideation, uncorrected hearing loss, or active substance abuse.
- PATIENTS
- Inclusion Criteria:
- ≥21 years of age;
- diagnosed within 60 days of initial screening with an advanced cancer, defined as metastatic and/or recurrent/progressive stage III/IV cancer, including brain, lung, breast, gynecologic, head and neck, gastrointestinal, genitourinary cancer, melanoma, and hematologic malignancies.
Key Trial Info
Start Date :
January 10 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
256 Patients enrolled
Trial Details
Trial ID
NCT04803604
Start Date
January 10 2022
End Date
June 30 2026
Last Update
January 27 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35294
2
Emory University
Atlanta, Georgia, United States, 30303